| It looks like drug approvals have well and truly bounced back. 2019’s total of 45 approvals may not have hit the record high posted in 2018, but it fits into a general upward trend. Some pin that on a “friendlier” FDA, while others think it is the natural outcome of the maturation of new treatment approaches.
|
